ProLiquitab

Bioavailability Enhancement

• Self Emulsified System in a Tablet
• Solubilized Drug Emulsion Adsorbed onto Solid Carrier
• Proprietary combinations of Excipients for Enhanced Solubility

Manufacturing Process

• 1. Disperse/Dissolve API into SEDDS
• 2. Adsorb SEDDS onto Solid Carrier
• 3. Granulate API Loaded Carrier
• 4. Blend with Additional Excipients
• 5. Tablet Compression

Graphic Depiction of ProLiquitab Matrix

ProLiquitab Comparison with Capsule Dosage Form

Potential Benefits:

• Improved Therapy
  • More rapid onset vs conventional tablet
  • Improved bioavailability
  • Lower PK variability
  • Higher blood levels
  • Lower API requirements
• Patient Preferred Tablet Dosage Form